Navigation Links
Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
Date:9/18/2013

RICHMOND, Calif., Sept. 18, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the sale of 6,100,000 shares of its common stock in an underwritten public offering at a price to the public of $10.58 per share, the closing price of the stock on the previous day. The gross proceeds to Sangamo from the public offering are expected to be approximately $65 million, before deducting underwriting discounts and commissions and other estimated offering expenses.  In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 915,000 shares of common stock on the same terms and conditions, to cover over-allotments, if any. The offering is expected to close on or about September 23, 2013, subject to customary closing conditions.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

Sangamo anticipates using the net proceeds from this offering for general corporate purposes, including support for its continuing research and development of its ZFP Therapeutic product candidates and research programs, commercialization activities, clinical trials, business development activities and, if opportunities arise, acquisitions of businesses, products, technologies or licenses that are complementary to its business.

Lazard Capital Markets LLC, JMP Securities LLC and Piper Jaffray & Co. are acting as joint book-running managers and Cowen and Company, LLC is acting as co-lead manager for the offering.  

A shelf registration statement on Form S-3 relating to the public offering of shares of common stock described above was filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on April 12, 2012. A preliminary prospectus supplement
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
2. Sangamo BioSciences to Acquire Ceregene
3. Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology
4. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
5. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
6. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
7. Sangamo BioSciences Reports First Quarter 2013 Financial Results
8. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
9. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
10. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
11. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... call systems," announced the high level interface capabilities ... ClinicAll infotainment systems. The partnership between ... entertainment terminals; this allows patients to choose the ... need and acuity. The advanced functionality of CarePlus™ ...
(Date:3/30/2015)... 30, 2015   MultiVir Inc. ("MultiVir"), a ... product candidates for the treatment of multiple oncological indications, ... statement on Form S-1 with the U.S. Securities and ... offering of shares of its common stock. The number ... for the proposed offering have not yet been determined. ...
(Date:3/30/2015)... , March 30, 2015 Sorrento Therapeutics, Inc. ... George K. Ng to the position of ... capacity, Mr. Ng will be responsible for all legal, ... joins the Company from BioDelivery Sciences International, Inc., where ... a member of senior management that led that company ...
Breaking Medicine Technology:NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2MultiVir Files Registration Statement for Proposed Initial Public Offering 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3
... Percutaneous Administration (CUPID) Data Highlight Safety Profile and ... 26 Celladon Corporation today announced that results ... advanced heart failure, including Phase 1/2 data of ... Zsebo, PhD, President and CEO, Celladon Corporation and ...
... 26 Senesco Technologies, Inc. ("Senesco" or the "Company") ... mouse influenza survival studies that were conducted in Dr. William Scheld,s ... Mice treated with an siRNA against Senesco,s Factor 5A gene ... rate for mice that received no treatment or a control siRNA.A ...
Cached Medicine Technology:Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 3
(Date:3/30/2015)... “We are pleased to announce three volunteer pilot ... in Los Angeles,” said Mark Wolper, Chair of Endeavor ... a nationwide call for nominations. , The awards ... Durden with LightHawk and Stephen Purello of Angel Flight ... will receive a $15,000 contribution from the Endeavor Awards ...
(Date:3/30/2015)... 30, 2015 Healthy, radiant skin can ... The staff of pharmacists is specially trained and skilled ... acne, eczema and other conditions. , Most people are ... dermatologist and/or PCP to tackle most skin conditions and ... has employed specialty-trained pharmacists who have experience in consulting ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 According to ... ), the hernia repair market will continue to dominate ... is occurring primarily due to increasing numbers of ventral ... them. , “The significantly large market share represented ... generally high ASP. We’re seeing a growing use of ...
(Date:3/30/2015)... City, UT (PRWEB) March 30, 2015 On ... Pop Business Owners Day. In honor of all small business ... Benefits will be spotlighting them. , According to Zane ... part of our economy, creating 75% of all jobs and ... in America account for 54% of all U.S. sales. The ...
(Date:3/30/2015)... This report studies the global ... forecast period of 2014 to 2019. This market ... 6.5% from 2014 to 2019. , Further Inquiry ... the global pharmacovigilance and drug safety software market ... basis of functionality, namely, adverse event reporting software, ...
Breaking Medicine News(10 mins):Health News:2015 Endeavor Awards Recipients Announced 2Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... through an animal study that Aspartame can cause lymphoma, ... five 20-ounce bottles of diet soda sweetened with aspartame ... ,The study would be published in March issue ... journal., ,The method and sample adopted were feeding ...
... short breaks can go a long way in making ... study conducted by Massachusetts Institute researchers. // ... Massachusetts Institute of Technology in Cambridge, found that rats' ... pause briefly to rest., ,They suggest that eliminating ...
... cell research in the state with the approval of 61% ... have impeded the initiative. // ,The officials now ... will be initiated. Zach Hall, president of the California Institute ... would commence the project as soon as possible. ...
... Howard has allocated $1.1 billion in health reforms. But his ... ,Mr. Howard said that there was more mental illness previously ... thing is to move on with one’s life. ... ill-informed. ,Though he said that in reality mental ...
... Honolulu: The Hawaii State Hospital has gone down the ranks ... crowding, a status report has revealed//. The status report quotes, ... to meet the June 30th deadline, required to bring the ... had received a one-year extended timeframe till June 30 to ...
... the help of prisoners from Beur jail in Patna to ... near the jail and begged for money to fulfill the ... was kidnapped in Phulwarisharief while he was on his way ... to use their contacts outside the jail to help trace ...
Cached Medicine News:Health News:Task Learning Made Simple By Taking Short Breaks 2Health News:Momentum of Stem cell research impeded by legal challenges 2
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: